Introduction
Kidney transplantation is the treatment of choice in young diabetic uraemic patients, since long-term dialysis can deteriorate the pre-existing diabetic macroangiopathy, thus reducing life expectancy. A major problem after kidney transplantation in diabetic patients is to achieve good metabolic control in patients receiving steroids. Pancreas transplantation, in association with kidney transplantation is proposed as a cure for diabetes in these patients . The positive effect of pancreas transplantation on diabetic polyneuropathy and retinopathy remains an object of debate (Ramsay 1988; Solders 1987; Secchi 1991; Bandello 1989) , while the prevention of recurrence of diabetic nephropathy on the transplanted kidney has been well demonstrated Bilous 1989) . The contrasting data reported on the effects of pancreas transplantation on long-term degenerative complications of diabetes could be the consequence of the advanced status of complications when patients undergo transplantation: it is well-known that when diabetic patients develop end-stage renal failure degenerative complications have reached the point of noreturn.
The leading causes of death in uraemic diabetic patients are vascular accidents, strictly related to the advanced degree of macro-angiopathy. Life survival in these patients, both when treated with dialysis or with kidney transplantation seems to be strictly correlated to the progression of macroangiopathy. The aim of our study was to evaluate: 1) the influence of kidney transplantation on life survival in uraemic diabetic patients, 2) the influence of pancreas transplantation on patient survival, kidney graft function and quality of life.
S142 Subjects and methods
Patients. Between April 1985 and December 1990, 84 Type I (insulindependent) diabetic uraemic patients were admitted to the kidney+pancreas transplantation program of our institute. Criteria of exclusion from the program were: severe dilated cardiomyopathy, severe peripheral angiopathy, severe coronary arteries disease and psycological unrelyability. 40 patients underwent transplantation. In 31 cases it was possible to perform a simultaneous kidney+pancreas transplantation (Group KP: age 38.8+1.4 years , duration of diabetes 24.7+1.1 years, duration of dialysis 16.9+_2.1 months ), while in 9 cases only the kidney was transplanted, due to technical reasons (Group K: age 37.5+_2.5 years, duration of diabetes 21.3+_2.5 years, duration of dialysis 20.6+_5.8). 44 patients are currently in waiting list (group HD : age 38.9-2_1.3 years, duration of diabetes 23.1+1.2 years, dialysis duration 33.9-L-_4.5 months) To evaluate the long-term effects of a functioning transplanted pancreas on kidney function, patients with a kidney graft functioning for more than 1 year were reanalyzed, and groups rearranged. Patients of the K group and patients of the KP group, who lost their pancreas for technical reasons (primary failure and thrombosis) within the first weeks of transplantation, constituted K(>lyear) Group (13 patients). Patients of the KP Group with a kidney function longer than 1 year and without technical failure of the pancreas eonsituted the KP(>lyear) Group (17 patients).
Surgical technique. The kidney graft was anastomozed to the iliac vessels of the recipient. The pancreas was transplanted in the eontratateral iliac fossa through an anastomosis of the splenic artery and vein (segmental technique with neoprene injection: 26 cases) to the iliac vessels of the recipent (Dubemard 1978 ) . In five cases a whole pancreas graft , with bladder diversion of the exocrine secretion was transplanted ( Sollinger 1988) . Patients of the HD group were treated with traditional haemodialysis (Bicarbonate or Acetate) three times weekly, and /or with more advanced techniques (biofiltration, PFD, Haemofiltration)
Statistical analysis. The rates of survival for patients and kidney were calculated according to the actuarial method (Culter 1968 ). The quality of life score was analyzed by chi-sqare test.
Quality of life. Quality of life was evaluated in patients of the K and KP groups before and after transplantation. It has been conceptualised along the following major dimensions: physical well-being, social well-being and working capacity. Physical wellbeing was measured by 5 multiple choice items (patients were asked how ill they are, how much of a problem their health is, how worded they are about their health, how restricted they are in activity and how their current and pretransplant health compare) and by a score (two items), based on the difficulty experienced in specific normal activity. Social well-being was measured by three multiple choice items (patients are asked whether they take part in leisure activities, whether they have hobbies and whether they attend recreative groups). Working capacity was evaluated by asking patients whether they work (part-time or full-time work). In case of unemployment the reasons were evaluated.
Results

Patient and kidney survival
Patients survival at 1, 3 and 5 years, calculated by the actuarial method, was 88%, 62%, and 51%, respectively, in the HD group, 88%, 88%,and 73%, respectively, in the K group, and 93%, 89%, and 89%
A. Secchi et al.: Quality of life after pancreas transplantation in the KP group. The causes of death were cardiovascular diseases (13 patients in the HI) group, 1 patient in the K group, and 2 patients in the KP group), infectious diseases (1 patient in the K group), post-surgical complications (1 patient in the KP group), hyperkaliaemia (5 patients in the HD group). Kidney graft survival at 1, 3, and 5 years was 76%, 61%, 31%, respectively, in the K group, while being 93%, 72%, 72%, respectively, in the KP group (Fig.l) .
Patient survival at 5 years was 78% in the K(>lyear) group and 100% in the KP(>lyear) group. The rate of kidney function at 3 and 5 years in these patients was 54% and 27% ,respectively, in the K(>lyear) group, while being 93% in the KP (>lyear) group. Acute kidney rejection episodes per patient were similar in the two groups ( 0.88_+0.20 in the KP group vs 0.85_+0.20 in the K group): kidney biopsies showed chronic rejection in all cases of kidney failure ( 
Quality of life
Results are shown in The metabolic effects of pancreas transplantation were the object of several investigations which have shown that it is capable of leading to insulin-independence, restoring a self-regulated source of insulin which correctly responds to insulinogenic stimuli (Pozza 1983 (Pozza , 1985 . In contrast, the effects of pancreas transplantation on long term degenerative complications of diabetes and its "protective" role on the transplanted kidney remain objects of discussion (Ramsay 1988; Solders 1987; Secchi 1991; Bandello 1989; Bilous 1989) .
The aim of our study was to evaluate the effects of kidney and pancreas transplantation on life survival of young uraemic diabetic patients. Although this is not a prospective study, we consider correct the retrospective allocation of patients to the K, KP or HD group, since criteria of inclusion into the study were similar for all patients (eligibility to transplant program), and criteria of allocation of patients to the 3 groups (K, KP, HD) were related to the possibility to receive a transplant, which is based on immunological matching. Our study has shown that kidney transplantation improves life expectancy of uremic diabetic patients (5 year survival: 73% vs 51%). The association of a pancreas can further improve patient survival ( 5 years: 89%). The leading causes of death in patients on dialysis are cariovascular accidents (13 cases: 29% of patients), while they account only for a low rate of death in K (1 case: 10% of patients) and in KP (2 cases: 6% of patients) groups. Although other influencing factors, such as arterial hypertension, can increase the risk of cardiovascular accidents in these patients, this cannot completely explain our results, since non-diabetic patients treated with dialysis and affected by arterial hypertension, have a higher survival rate (Schleibner 1988 ) than diabetic patients. It is likely that the transplanted pancreas and kidney exert a protective role on the furher progression of diabetic macro-angiopathy in these patients. The role played by the transplanted pancreas on kidney survival remains unclear. From our data, when we consider patients with a kidney functioning for more than 1 year, it appears that the kidney has a longer survival when it is associated to a pancreas graft. This is not the consequence of the prevention of diabetic nephropathy on the transplanted kidney, since the histological diagnosis in all cases of renal failure was chronic rejection. We have also evaluated whether a transplanted pancreas can further improve quality of life of diabetic patients submitted to kidney transplantation, since it was previously demonstrated that a kidney transplant "per se " can improve quality of life of non-diabetic uremic patients (Simmons 1987) . Only few studies are known on this subject (Nakache 1989) . Our data show that diabetic patients receiving a simultaneous kidney and pancreas transplantation enjoy a better quality of life than S 144 diabetic patients submitted to kidney transplantation alone. This is particularly evident for the physical we/1 being and for the social life, while working capacity and physical activities are similar in the two groups of patients. From these data it appears evident that the better quality\bf life enjoyed by patients receiving a pancreas and kidney transplantation is the consequence of a better psychological rather than physical condition. In conclusion kidney transplantation offer a better life expectancy than dialysis to young uremic diabetic patients. An associated pancreas transplant can further improve life expectancy in these patients. Pancreas transplantation improves quality of life of diabetic patients by improving their psychological performance.
